Evaluation of Discordance Measures in Oncology Studies with Blinded Independent Central Review of Progression-Free Survival Using an Observational Error Model

Author： Mannino F. V.   Amit O.   Lahiri S.  

Publisher： Taylor & Francis Ltd

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.23, Iss.5, 2013-09, pp. : 971-985

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials

By Denne J. S.   Stone A. M.   Bailey-Iacona R.   Chen T.-T.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 951-970

Taylor & Francis Ltd

Access to resources Recommend Favorite

Evaluating and Adjusting for Premature Censoring of Progression-Free Survival

By Rothmann Mark   Koti Kallappa   Lee Kyung Yul   Lu Hong Laura   Shen Yuan Li   Zhang Jenny J.   Jin Mei   Zhou Haojin  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 1091-1105

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Review of Statistical Issues with Progression-Free Survival as an Interval-Censored Time-to-Event Endpoint

By Sun Xing   Li Xiaoyun   Chen Cong   Song Yang  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 986-1003

Taylor & Francis Ltd

Access to resources Recommend Favorite

HIV-1 immunogen does not appear to improve HIV progression-free survival

By  

Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Improving progression-free and overall survival in patients with cancer: a potential role for bisphosphonates

By Lipton Allan  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. : 749-762

Informa Healthcare

Access to resources Recommend Favorite